G2A (GPR132)

在2003年,Ludwig 等人首次描述了氢离子感受型G蛋白偶联受体 (proton-sensing G-protein coupled receptors (GPCRs)) 家族,该家族包括四个成员,均属于GPCRs Class A:GPR4、TDAG8 (GPR65)、OGR1 (GPR68) 和G2A (GPR132)。

G2A (GPR132),简称G2A,是一种应激诱导型受体,其表达在DNA损伤后增强,导致细胞周期在G2/M期停滞。因此,选择了“G2-细胞周期停滞”作为受体的名称来源。G2A主要在白细胞中表达,负责巨噬细胞的迁移。有趣的是,G2A 也在表达TRPV1通道的外周感觉神经元中表达。在这些神经元中,G2A似乎与TRPV1沟通,并通过蛋白激酶C增强其活性,从而在草酸铂引起的神经病理性疼痛中发挥作用。

G2A是四个受体中对氢离子最不敏感的,其通过Gq 途径激活产生肌醇三磷酸 (IP3)。它在pH 7.4时被激活,随着pH从8.2降低到6.6,反应单调增加。G2A被提议作为脂质受体,后来又被撤回。似乎溶血磷脂不是直接的激活剂,而是参与G2A到达细胞膜的运输。溶血磷脂也作为T细胞迁移的趋化剂通过G2A。另一项研究发现LPC可能是G2A的弱拮抗剂,但所需的浓度很高 (>10 µM)。在异源表达系统中,最强的G2A激活是由亚油酸代谢物9S-HODE引起的 (EC50:约0.5 µM)。最近的研究还发现了N-棕榈酰甘氨酸和N-亚油酸甘氨酸作为G2A的激活剂,其效力与9-HODE相似,这加强了G2A作为信号脂质受体的概念,而不是氢离子和酸化的受体。在同一研究中,还发现了血管紧张素II型受体拮抗剂Telmisartan及其类似物GSK1820795A作为有效的G2A抑制剂。在肿瘤微环境中,G2A 被建议沉默肿瘤相关巨噬细胞 (TAMs)。乳腺癌肿瘤细胞产生乳酸,可以激活TAMs中的G2A,使其保持非侵略性的M2样状态,并增强肿瘤生长。

The family of proton-sensing G-protein coupled receptors (GPCRs) has first been described by Ludwig et al. in 2003 and consists of four members that belong to the class A orphan GPCRs: GPR4, TDAG8 (GPR65), OGR1 (GPR68), and G2A (GPR132).


G2A (GPR132), the abbreviation, G2A, is a stress-induced receptor and that its expression is enhanced upon DNA damage, leading to cell cycle arrest in the G2/M phase. The term: “G2-cell cycle arrest” was chosen as a name for the receptor. G2A is mainly expressed in leukocytes and seems to be responsible for the migration of macrophages. Interestingly, G2A is also expressed in peripheral sensory neurons that co-express the TRPV1 channel. In these neurons, G2A seems to communicate with TRPV1 and enhance its activity via protein kinase C during oxaliplatin-induced neuropathic pain.


G2A is the least sensitive to protons among four receptors, and its activation leads to the production of inositol trisphosphate (IP3) through Gq activation. It is activated at pH 7.4, with the response increasing monotonously as the pH decreases from 8.2 to 6.6. G2A is proposed as a receptor for lipids, especially lysophospholipids. Which was later retracted. It seems that lysophospholipids are not direct activators but are involved in the trafficking of G2A to the plasma membrane. Lysophospholipids also act as chemoattractants for T-cell migration through G2A. Another study found that LPC may be a weak antagonist of G2A, but the required concentrations are high (>10 µM). The strongest G2A activation was caused by linoleic acid metabolite 9S-HODE (EC50: ~0.5 µM) in a heterologous expression system. A recent study also identified N-palmitoylglycine and N-linoleoylglycine as G2A activators with similar potency to 9-HODE, reinforcing the concept of G2A as a receptor for signaling lipids rather than protons and acidification. In the same study, the angiotensin-II type I receptor antagonist telmisartan and its analogue GSK1820795A were identified as potent G2A inhibitors.


In the tumor microenvironment, G2A has been suggested to silence tumor-associated macrophages (TAMs). Breast tumor cells produce lactate, which can activate G2A in TAMs non-aggressive M2-like state and enhancing tumor growth. G2A may thus be a novel target for breast cancer.


共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(±)11(12)-EET methyl ester
11,12-EET methyl ester; (±)11,12-EpETrE methyl ester

(±)11(12)-EET methyl ester (11,12-EET-methyl ester) 是 11,12-环氧二十碳三烯酸 (11,12-EET) (MS-S44454) 的甲基化衍生物,无法诱导 G 蛋白偶联受体 GPR132 的 β-arrestin 募集,也不能增强造血干细胞和祖细胞 (HSPC) 标志物的表达,可作为阴性对照用于研究 11,12-EET 的结构-功能关系,促进分析氧化脂肪酸-GPR132 信号轴在造血中的作用。

90693-45-1
Activator
(±)11(12)-EET methyl ester

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础